Transforming medicine with novel early stage therapies that eliminate disease-causing proteins #proteindegradation
Location: United States, Massachusetts, Watertown
Employees: 51-200
Total raised: $243M
Founded date: 2016
Investors 8
Funding Rounds 2
Date | Series | Amount | Investors |
16.06.2020 | - | $170M | - |
07.01.2016 | Series A | $73M | - |
Mentions in press and media 10
Date | Title | Description | Source |
05.03.2024 | C4 Therapeutics to Present New Preclinical Data on Highly Se... | - | globenewsw... |
24.05.2021 | Eliem Therapeutics Announces $60 Million Series B Financing | prnewswire... | |
24.05.2021 | Eliem Therapeutics, Inc. announced that it has received $60 ... | On May 24, 2021, Eliem Therapeutics, Inc. closed the transaction. The company announced that it has ... | marketscre... |
19.10.2020 | ONK Therapeutics Closes US$8M Financing | ONK Therapeutics Ltd, a Galway, Ireland-based natural killer (NK) cell therapy company, raised US$8M... | finsmes.co... |
17.06.2020 | C4 Therapeutics Raises $170 Million Financing to Bring Robus... | - | 3ebiovc.co... |
16.06.2020 | C4 Therapeutics Raises $170M in Funding | C4 Therapeutics, Inc., a Watertown, Mass.-based biotechnology company pioneering a new class of smal... | finsmes.co... |
04.01.2019 | Joining forces with Skyhawk, C4 Therapeutics, Biogen b... | These days at Biogen, the spotlight tends to fall on one of two programs: Its commercial SMA dr... | endpts.com... |
04.01.2018 | Pfizer and Arvinas sign $830M drug development deal that tar... | So what’s attracting the big fish? There are no clinical programs tied up in any of the deals. Inste... | medcitynew... |
07.01.2016 | C4 Therapeutics Closes $73M Series A Financing | C4 Therapeutics, a Cambridge, MA-based developer of novel treatments in the field of targeted protei... | finsmes.co... |
- | Pfizer and Arvinas sign $830M drug development deal that tar... | New Haven, Connecticut-based Arvinas has signed a new deal with Pfizer that could be worth up to $83... | medcitynew... |